4//SEC Filing
Protalix BioTherapeutics, Inc. 4
Accession 0001144204-17-027803
$PLXCIK 0001006281operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 9:31 AM ET
Size
4.7 KB
Accession
0001144204-17-027803
Insider Transaction Report
Form 4
Manor Moshe
President & CEO
Transactions
- Purchase
Common Stock
2017-05-16$0.81/sh+50,000$40,500→ 50,000 total
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 9:31 AM ET
- Size
- 4.7 KB